Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05858307

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This study aims to assess the association of Anti-Müllerian hormone (AMH) with polycystic ovarian syndrome, premature ovarian insufficiency and fertility. The main objectives include the following: 1. To study the level of serum AMH in women with PCOS and to evaluate the utility of serum AMH in the diagnosis of PCOS. 2. To evaluate the level of serum AMH in women with POI and to evaluate the utility of serum AMH in the management of POI. 3. To evaluate the associations of basal AMH level with FSH level and AFC respectively for women undergoing ART treatment. 4. To determine the optimal regimen of gonadotropin for ovarian stimulation for women undergoing ART treatment. 5. To evaluate the predictive value of serum AMH in reproductive outcomes including oocyte quality, embryo quality, pregnancy loss, clinical pregnancy and live birth rate in women undergoing ART treatment.

Key Details

Gender

FEMALE

Age Range

10 Years - 44 Years

Study Type

OBSERVATIONAL

Enrollment

300

Start Date

2022-06-22

Completion Date

2026-12-31

Last Updated

2025-03-27

Healthy Volunteers

No

Locations (1)

The Chinese University of Hong Kong

Hong Kong, Hong Kong